--- title: "XIHARI shareholder Fengying Anchuang plans to reduce its holdings by no more than 3%" type: "News" locale: "en" url: "https://longbridge.com/en/news/233096886.md" description: "According to the announcement from XIHARI, the company's shareholder Beijing Fengying Anchuan Enterprise Management Consulting Center (Limited Partnership) (referred to as \"Fengying Anchuan\") plans to reduce its holdings of the company's shares by no more than 9.4974 million shares, which is no more than 3% of the company's total share capital, during the period from April 17, 2025, to July 16, 2025" datetime: "2025-03-25T10:07:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/233096886.md) - [en](https://longbridge.com/en/news/233096886.md) - [zh-HK](https://longbridge.com/zh-HK/news/233096886.md) --- # XIHARI shareholder Fengying Anchuang plans to reduce its holdings by no more than 3% According to the announcement from XIHARI (688334.SH), the company's shareholder Beijing Fengying Anchuan Enterprise Management Consulting Center (Limited Partnership) (referred to as "Fengying Anchuan") plans to reduce its holdings of the company's shares by no more than 9.4974 million shares, which is no more than 3% of the company's total share capital, between April 17, 2025, and July 16, 2025 ### Related Stocks - [688334.CN](https://longbridge.com/en/quote/688334.CN.md) ## Related News & Research - [04:05 ETVolta Labs launches automated library preparation solution for the Oxford Nanopore Ligation Sequencing Kit V14](https://longbridge.com/en/news/287180129.md) - [Intel CEO says foundry business is gaining momentum as customer interest grows](https://longbridge.com/en/news/286826548.md) - [Adelayde Exploration completes airborne survey at Sisson North tungsten project in New Brunswick](https://longbridge.com/en/news/287171941.md) - [02:50 ETPowerbox wprowadza na rynek serię wytrzymałych przetworników DC/DC do zastosowań w sektorze obronnym](https://longbridge.com/en/news/286867266.md) - [US working with small biotech firm on experimental Ebola treatment, Bloomberg News reports](https://longbridge.com/en/news/287108072.md)